InvestorsHub Logo

Johnny_C

02/16/19 11:19 AM

#47641 RE: rawman #47640

Not at all my friend, in fact VTGN is in better position than ever. J&J most likely will get a black box label and there were long term efficacy issues.

Read it and weep. VTGN may very well be in big pharma crosshairs after data comes out.


https://finance.yahoo.com/news/fda-panel-nod-j-js-170323319.html

clearmont88

02/17/19 9:26 AM

#47643 RE: rawman #47640

I’m not sure why the daily fluctuations of VTGN have to be discussed as nauseum on this Board. You are Correct - It was a bad day for VTGN share price

And it did hurt Tauriga’s balance sheet very short term

However, what if next week it closed higher? I’m not saying it will, but do we have to get into this habit of discussing daily fluctuations?

I believe that Tauriga will hold its VTGN (or a large % of it) till data event, which is public info - will occur later this Calendar Year

There are no guarantees of anything. There are risks here for sure - but things also may work out positively

It’s better in life to be fair and balanced - it’s also common decency

diannedawn

02/26/19 8:50 AM

#47649 RE: rawman #47640

Or maybe someone got wind of the offering that was coming???
Sell sell sell and reload after the crash???
But make sure you keep peddling the BUY BUY BUY party line!!!
Gotta have someone to buy the shares being dumped...lol
It’s really too bad that the SEC does not have the wherewithal to crack down on the BS we see on a regular basis!
SMH